Bosh sahifa87S • FRA
add
Roivant Sciences Ltd
Yopilish kursi
8,70 €
Kunlik diapazon
9,14 € - 9,15 €
Yillik diapazon
7,98 € - 12,11 €
Bozor kapitalizatsiyasi
7,44 mlrd USD
Oʻrtacha hajm
4,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Defense World
2 kun oldin
Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Purchased by Bank of Montreal Can
3,78%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 9,02 mln | -42,05% |
Joriy xarajat | 132,34 mln | 31,07% |
Sof foyda | 169,38 mln | -96,68% |
Sof foyda marjasi | 1,88 ming | -94,26% |
Har bir ulushga tushum | -0,20 | 4,01% |
EBITDA | -261,54 mln | -42,81% |
Amaldagi soliq stavkasi | 10,90% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 5,15 mlrd | -22,85% |
Jami aktivlari | 5,79 mlrd | -20,79% |
Jami passivlari | 256,38 mln | -64,79% |
Umumiy kapital | 5,54 mlrd | — |
Tarqatilgan aksiyalar | 713,55 mln | — |
Narxi/balansdagi bahosi | 1,21 | — |
Aktivlardan daromad | -10,98% | — |
Kapitaldan daromad | -11,69% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 169,38 mln | -96,68% |
Operatsiyalardan naqd pul | -207,25 mln | 1,52% |
Sarmoyadan naqd pul | 454,07 mln | -91,32% |
Moliyadan naqd pul | -272,95 mln | -215,34% |
Naqd pulning sof oʻzgarishi | -27,20 mln | -100,52% |
Boʻsh pul | -303,56 mln | -321,65% |
Haqida
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel. Wikipedia
CEO
Tashkil etilgan
7-apr, 2014
Sayt
Xodimlar soni
908
